Detection and significance of serum protein markers of small-cell lung cancer

Journal of Clinical Laboratory Analysis

Volumn 22, Issue 2, 2008, Pages 131-137

  Han, Mingyong ^a   Liu, Qi ^a   Yu, Jiekai ^b   Zheng, Shu ^b  

^a SHANDONG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Biomarker; Diagnosis; Lung cancer; Proteomics; SELDI TOF MS

Indexed keywords

BIOLOGICAL MARKER; NEURON SPECIFIC ENOLASE; PLASMA PROTEIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BIOINFORMATICS; CANCER SCREENING; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PNEUMONIA; PROTEIN MICROARRAY; PROTEOMICS; SENSITIVITY ANALYSIS; SUPPORT VECTOR MACHINE; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY;

ADULT; AGED; BLOOD PROTEINS; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; CASE-CONTROL STUDIES; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PNEUMONIA; REPRODUCIBILITY OF RESULTS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR MARKERS, BIOLOGICAL;

EID: 42149182500     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.20230     Document Type: Article

References (31)

1. Manegold C., Thatcher N. Survival improvement in thoracic cancer: progress from the last decade and beyond. Lung Cancer 2007;57:S3-S5.
2. Granetzny A, Boseila A, Wagner W, et al. Surgery in the trimodality treatment of small cell lung cancer: stage-dependent survival. Eur J Cardiothorac Surg 2006;30:212-216.
3. Bharti A, Ma PC, Salgia R. Biomarker discovery in lung cancer-promises and challenges of clinical proteomics. Mass Spectrom Rev 2007;26:451-466.
4. Arita T, Kuramitsu T, Kawamura M, et al. Bronchogenic carcinoma: incidence of metastasis to normal sized lymph nodes. Thorax 1995;50:1257-1269.
5. Hatzakis KD, Froudarakis ME, Bouros D, Tzanakis N, Karkavitsas N, Siafakas NM. Prognostic value of serum tumor markers in patients with lung cancer. Respiration 2002;69:25-29.
6. Lee JH, Chang JH. Diagnostic utility of serum and pleural fluid carcinoembryonic antigen, neuron specific enolase and cytokeratin 19 fragments in patients with effusion from primary lung cancer. Chest 2005;128:2298-2303.
7. Pujol JL, Quantin X, Jacot W, Boher JM, Grenier J, Lamy PJ. Neuroendocrine and cytokeratin serum markers as prognostic determinants of small cell lung cancer. Lung Cancer 2003;39:131-138.
8. Titulaer MK, Siccama I, Dekker LJ, et al. A database application for pre-processing, storage and comparison of mass spectra derived from patients and controls. BMC Bioinformatics 2006;7:403.
9. Jemal A, Murray T, Samuels A, Chafoor A, Ward E, Thun MJ. Cancer statistics, 2003. CA Cancer J Clin 2003;53:5-6.
10. Engwegen JY, Gast MC, Schellens JH, Beijnen JH. Clinical proteomics: searching for better tumour markers with SELDITOF mass spectrometry. Trends Pharmacol Sci 2006;27:251-259.
11. Yu Y, Chen S, Wang LS, et al. Prediction of pancreatic cancer by serum biomarkers using surface-enhanced laser desorption/ionization-based decision tree classification. Oncology 2005;68:79-86.
12. Petricoin EF, Liotta LA. SELDI-TOF-based serum proteomic pattern diagnostics for early detection of cancer. Curr Opin Biotechnol 2004;15:24-30.
13. Petricoin EF, Ardekani AM, Hitt BA, et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet 2002;359:572-577.
14. Li J, Zhang Z, Rosenzweig J, Wang YY, Chan DW. Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer. Clin Chem 2002;48:1296-1304.
15. Vlahou A, Laronga C, Wilson L, et al. A novel approach toward development of a rapid blood test for breast cancer. Clin Breast Cancer 2003;4:203-209.
16. Koopmann J, Zhang Z, White N, et al. Serum diagnosis of pancreatic adenocarcinoma using surface-enhanced laser desorption and ionization mass spectrometry. Clin Cancer Res 2004;10:860-868.
17. Chen YD, Zheng S, Yu JK, Hu X. Artificial neural networks analysis of surface-enhanced laser desorption/ionization mass spectra of serum protein pattern distinguishes colorectal cancer from healthy population. Clin Cancer Res 2004;10:8380-8385.
18. DeAngelis LM. Brain tumors. N Engl J Med 2001;344:114-123.
19. Mannes AJ, Martin BM, Yang HY, et al. Cystatin C as a cerebrospinal fluid biomarker for pain in humans. Pain 2003;102:251-256.
20. Yip TT, Chan JW, Cho WC, et al. Protein chip array profiling analysis in patients with severe acute respiratory syndrome identified serum amyloid a protein as a biomarker potentially useful in monitoring the extent of pneumonia. Clin Chem 2005;51:47-55.
21. Zelen M. Keynote address on biostatistics and data retrieval. Cancer Chemother Rep 1973;4:31-42.
22. Liu Y. Active learning with support vector machine applied to gene expression data for cancer classification. J Chem Inf Comput Sci 2004;44:1936-1941.
23. Lin HH, Han LY, Cai CZ, Ji ZL, Chen YZ. Prediction of transporter family from protein sequence by support vector machine approach. Proteins 2006;62:218-231.
24. Nelson DI, Concha-Barrientos M, Driscoll T, et al. The global burden of selected occupational diseases and injury risks: methodology and summary. Am J Ind Med 2005;48:400-418.
25. Seibert V, Wiesner A, Buschmann T, Meuer J. Surface-enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI TOF-MS) and ProteinChip technology in proteomics research. Pathol Res Pract 2004;200:83-94.
26. Somorjai RL, Dolenko B, Baumgartner R. Class prediction and discovery using gene microarray and proteomics mass spectroscopy data: curses, caveats, cautions. Bioinformatics 2003;19:1481-1491.
27. Furey TS, Cristianini N, Duffy N, Bednarski DW, Schummer M, Haussler D. Support vector machine classification and validation of cancer tissue samples using microarray expression data. Bioinformatics 2000;16:906-914.
28. Byvatov E, Schneider G. Support vector machine applications in bioinformatics. Appl Bioinformatics 2003;2:67-77.
29. Jorissen RN, Gilson MK. Virtual screening of molecular databases using a s support vector machine. J Chem Inf Model 2005;45:549-561.
30. Wiesner A. Detection of tumor markers with proteinchip technology. Curr Pharm Biotechnol 2004;5:45-67.
31. Liu Y, Sturgis CD, Grzybicki DM, et al. Microtubule-associated protein-2: a new sensitive and specific marker for pulmonary carcinoid tumor and small cell carcinoma. Mod Pathol 2001;14:880-885.